DXCM — DEXCOM INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1093557 ·
Last close
$83.45
Market Cap
$32.20B
52W High
$84.70
52W Low
$57.66
ADV30
4,952,965
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,191,900,000 | 750,300,000 | 255,300,000 | 199,500,000 | 6,633,300,000 | 1,118,200,000 | 3,676,400,000 |
| Dec 2025 | 1,259,600,000 | 792,700,000 | 323,000,000 | 267,300,000 | 6,339,900,000 | 917,700,000 | 3,593,900,000 |
| Sep 2025 | 1,209,300,000 | 731,400,000 | 242,500,000 | 283,800,000 | 7,500,000,000 | 1,835,700,000 | 4,773,900,000 |
| Jun 2025 | 1,157,100,000 | 688,800,000 | 212,600,000 | 179,800,000 | 7,327,000,000 | 1,159,000,000 | 4,753,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,782,500,000
Investing CF
$137,300,000
Financing CF
$-1,723,900,000
CapEx
$-353,100,000
Dividends Paid
—
Buybacks
$-1,062,800,000
EPS Diluted TTM
$2.34
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$2,633,400,000
Inventory
$693,600,000
Receivables
$1,105,200,000
ST Investments
$1,297,000,000
EBIT TTM
$1,220,300,000
Pretax Income TTM
$1,203,600,000
Interest Exp TTM
$16,700,000
Analysts
24
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,969,200,128
EBITDA
$1,402,099,968
Free Cash Flow
$1,056,637,504
Enterprise Value
$27,530,496,000
Total Cash
$1,947,000,064
Total Debt
$1,346,099,968
Shares Out
385,872,977
Trailing EPS
$2.31
Book Value
$7.66
ROE
38.5%
ROA
10.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,662,000,000 | 911,800,000 | 836,300,000 | 6,339,900,000 | 3,593,900,000 | — | 1,440,700,000 |
| Dec 2024 | 4,033,000,000 | 600,000,000 | 576,200,000 | 6,484,500,000 | 4,381,900,000 | — | 989,500,000 |
| Dec 2023 | 3,622,300,000 | 597,700,000 | 541,500,000 | 6,264,500,000 | 4,195,900,000 | — | 748,500,000 |
| Dec 2022 | 2,909,800,000 | 391,200,000 | 341,200,000 | 5,391,700,000 | 3,259,900,000 | — | 669,500,000 |
TTM Snapshot
Revenues TTM
$3,389,000,000
NetIncome TTM
$443,800,000
OpCashFlow TTM
$0
Assets (Latest)
$6,484,500,000
Forward EPS
$3.08
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MDLN | Medline Inc. | $33.22B | $39.28 | — |
| GEHC | GE HealthCare Technologies Inc. | $30.94B | $68.02 | — |
| FSNUF | Fresenius SE & Co. KGaA | $30.61B | $54.35 | — |
| RMD | RESMED INC | $30.60B | $210.98 | — |
| FSNUY | Fresenius SE & Co. KGaA | $29.09B | $12.91 | — |
News headlines (Yahoo Finance, 1h cache)
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
2026-07-31 17:41 · Yahoo
Dexcom tweaks full-year outlook after reporting 13% growth in Q2
2026-07-31 15:20 · Yahoo
Why Is DexCom (DXCM) Stock Rocketing Higher Today
2026-07-31 14:59 · Yahoo
DexCom Inc (DXCM) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
2026-07-31 05:04 · Yahoo
DexCom (DXCM) Q2 2026 Earnings Call Transcript
2026-07-31 01:32 · Yahoo
DexCom, Inc. Q2 2026 Earnings Call Summary
2026-07-31 01:17 · Yahoo
DexCom Q2 Earnings Call Highlights
2026-07-30 23:04 · Yahoo
DexCom (DXCM) Q2 Earnings and Revenues Top Estimates
2026-07-30 21:25 · Yahoo
DexCom’s (NASDAQ:DXCM) Q2 CY2026 Sales Beat Estimates
2026-07-30 20:12 · Yahoo
Dexcom Reports Second Quarter 2026 Financial Results
2026-07-30 20:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.